← All trials
NCT07074327
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 11, 2025
- Primary completion
- Jun 29, 2026
- Completion date
- Jul 4, 2026
- First posted
- Jul 20, 2025
- Last posted
- Aug 12, 2025
- Enrollment
- 148
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- VertexLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.